Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel P. Petrylak, MD
Herbert Irving Comprehensive Cancer Center
Study Chair - George Wilding, MD
University of Wisconsin, Madison
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pretoria Academic Hospitals
Pretoria, South Africa
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago
Chicago, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Duluth
Duluth, Minnesota, United States
- Veterans Affairs Medical Center - Minneapolis
Minneapolis, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Veterans Affairs Medical Center - East Orange
East Orange, New Jersey, United States
- Ccop - Northern New Jersey
Hackensack, New Jersey, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- Ccop - Merit Care Hospital
Fargo, North Dakota, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Ccop - Toledo Community Hospital Oncology Program
Toledo, Ohio, United States
- Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
- Ccop - Mainline Health
Wynnewood, Pennsylvania, United States
- Ccop - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus
Nashville, Tennessee, United States
- University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States
- Veterans Affairs Medical Center - Madison
Madison, Wisconsin, United States
- Ccop - Marshfield Medical Research and Education Foundation
Marshfield, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Veterans Affairs Medical Center - Milwaukee (zablocki)
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 1996
- Primary completion
- 31 Aug 2002
- Completion
- 31 Mar 2008
- Last update posted
- 28 Feb 2013
- Registered enrollment
- 390
- Registry id
- NCT00002723
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.